Key Insights

Highlights

Success Rate

95% trial completion (above average)

Research Maturity

75 completed trials (33% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.8%

4 terminated out of 224 trials

Success Rate

94.9%

+8.3% vs benchmark

Late-Stage Pipeline

12%

27 trials in Phase 3/4

Results Transparency

7%

5 of 75 completed with results

Key Signals

5 with results95% success

Data Visualizations

Phase Distribution

166Total
Not Applicable (73)
P 1 (10)
P 2 (56)
P 3 (23)
P 4 (4)

Trial Status

Completed75
Unknown72
Recruiting49
Not Yet Recruiting14
Active Not Recruiting10
Terminated4

Trial Success Rate

94.9%

Benchmark: 86.6%

Based on 75 completed trials

Clinical Trials (224)

Showing 20 of 20 trials
NCT06525402Not ApplicableRecruiting

Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemotherapy

NCT07844057Phase 2Not Yet Recruiting

First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma

NCT07842679Not Yet Recruiting

Cognitive Impairment in Older Adults With Hematologic Malignancies

NCT05550415Phase 2Recruiting

The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer

NCT06863623Not ApplicableCompleted

The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients

NCT04724499Not ApplicableActive Not Recruiting

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy

NCT05776758Phase 3Active Not Recruiting

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

NCT05014399Recruiting

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

NCT06510010Phase 2RecruitingPrimary

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

NCT06490003Recruiting

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

NCT04694885Not ApplicableActive Not Recruiting

Quality of Life Improvement During Chemotherapy

NCT04489173Phase 2Completed

TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer

NCT04636255Not ApplicableCompleted

Physical Capacity in Hodgkin Lymphoma Survivors

NCT07561892Phase 4Recruiting

Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).

NCT06892158Not ApplicableRecruiting

Massage Impact on Sleep in Pediatric Oncology

NCT05515796Phase 2Completed

Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors

NCT06313203Phase 2Recruiting

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

NCT07372443Not ApplicableNot Yet Recruiting

Photobiomodulation in the Prevention and Management of Oral Mucositis in Children

NCT06533670Active Not Recruiting

TME Alteration in HER2 Positive Breast Cancer

NCT06844695Not ApplicableCompletedPrimary

Effects of Virtual Museum Visit on Pain, Fatigue, and Anxiety in Patients Receiving Chemotherapy

Scroll to load more

Research Network

Activity Timeline